Published in Basic Clin Pharmacol Toxicol on March 01, 2006
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88
Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ (2011) 3.74
Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol (2009) 1.33
Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res (2007) 0.95
Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci (2013) 0.91
Pharmacovigilance for psychiatrists: An introduction. Indian J Psychiatry (2014) 0.83
Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil. PLoS One (2012) 0.81
Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study. JAMA Intern Med (2013) 0.80
Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure. Pflugers Arch (2015) 0.78
Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option? Clin Pract Epidemiol Ment Health (2015) 0.76
Selective serotonin reuptake inhibitor and bleeding in a cynomolgus macaque (Macaca fascicularis). Comp Med (2014) 0.76
Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol (2012) 0.75
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ (2012) 2.39
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum (2005) 2.35
Incidence and risk factors for psoriasis in the general population. Arch Dermatol (2007) 2.12
Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control (2005) 1.80
[Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors]. Gac Sanit (2005) 1.69
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care (2010) 1.32
Hormonal therapies and meningioma: is there a link? Cancer Epidemiol (2011) 1.06
Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology (Oxford) (2011) 0.98
A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol (2004) 0.98
Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism. Thromb J (2008) 0.91
Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. Front Pharmacol (2010) 0.91
Use of antidepressants and risk of lung cancer. Cancer Causes Control (2007) 0.90
Upper gastrointestinal complications among users of paracetamol. Basic Clin Pharmacol Toxicol (2006) 0.85
Use of antipsychotic agents in Spain through 1985-2000. Eur Psychiatry (2002) 0.85
[Acute hepatitis associated with Colpachi intake. Apropros of 5 cases]. Gastroenterol Hepatol (2007) 0.77
Olmesartan for the prevention or delay of diabetic nephropathy: some considerations. Rev Esp Cardiol (Engl Ed) (2012) 0.75
[Spanish pharmacovigilance system of vaccines]. Med Clin (Barc) (2011) 0.75
Labor induction with dinoprostone or oxytocine and postpartum disseminated intravascular coagulation: a hospital-based case-control study. Am J Obstet Gynecol (2004) 0.75
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme. Pharmacoepidemiol Drug Saf (2006) 0.75
[Tetrabamate and a benefit-risk ratio]. Med Clin (Barc) (2002) 0.75
[Clinical-Epidemiological Profile of Patients Initiating Intensive Statin Therapy for the Secondary Prevention of Vascular Disease in Spain]. Rev Esp Salud Publica (2015) 0.75